MARKET

GBT

GBT

Global Blood
NASDAQ

Real-time Quotes | Nasdaq Last Sale

48.81
-1.43
-2.85%
Opening 12:49 11/14 EST
OPEN
50.00
PREV CLOSE
50.24
HIGH
50.23
LOW
48.21
VOLUME
270.40K
TURNOVER
--
52 WEEK HIGH
64.94
52 WEEK LOW
30.15
MARKET CAP
2.94B
P/E (TTM)
-12.5592
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GBT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GBT News

  • Global Blood's (GBT) Q3 Loss Widens, Voxelotor in Focus
  • Zacks.6d ago
  • Global Blood Therapeutics EPS misses by $0.01
  • seekingalpha.6d ago
  • Global Blood Therapeutics Q3 EPS $(1.07) Misses $(1.05) Estimate
  • Benzinga.6d ago
  • GBT Reports Recent Business Progress and Third Quarter 2019 Financial Results
  • GlobeNewswire.6d ago

More

Industry

Biotechnology & Medical Research
-0.17%
Pharmaceuticals & Medical Research
-0.54%

Hot Stocks

Name
Price
%Change

About GBT

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company is developing its initial product candidate, GBT440, as an oral, once-daily therapy for sickle cell disease (SCD). The Company is evaluating GBT440 in SCD in a Phase III clinical trial of GBT440 in adult and adolescent patients with SCD. GBT440 inhibits abnormal hemoglobin polymerization, the underlying mechanism of RBC sickling. The Company is also engaged in other research and development activities targeted towards hereditary angioedema (HAE). The Company's GBT440 is an investigational drug that increases hemoglobin's affinity for oxygen by binding to the alpha-chain of hemoglobin. GBT440 has been observed to keep a proportion of sickle hemoglobin (HbS), in its oxygenated state, where it cannot participate in polymerization.
More

Webull offers Global Blood Therapeutics Inc (GBT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.